Email updates

Keep up to date with the latest news and content from BioData Mining and BioMed Central.

Open Access Short report

Multivariate methods and software for association mapping in dose‐response genome‐wide association studies

Chad C Brown13, Tammy M Havener2, Marisa Wong Medina4, Ronald M Krauss4, Howard L McLeod2 and Alison A Motsinger‐Reif13*

Author Affiliations

1 Department of Statistics, North Carolina State University, Raleigh, NC, USA

2 Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

3 Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA

4 , Children’s Hospital Oakland Research Institute, Oakland, CA 94609, USA

For all author emails, please log on.

BioData Mining 2012, 5:21  doi:10.1186/1756-0381-5-21

Published: 12 December 2012

Abstract

Background

The large sample sizes, freedom of ethical restrictions and ease of repeated measurements make cytotoxicity assays of immortalized lymphoblastoid cell lines a powerful new in vitro method in pharmacogenomics research. However, previous studies may have over‐simplified the complex differences in dose‐response profiles between genotypes, resulting in a loss of power.

Methods

The current study investigates four previously studied methods, plus one new method based on a multivariate analysis of variance (MANOVA) design. A simulation study was performed using differences in cancer drug response between genotypes for biologically meaningful loci. These loci also showed significance in separate genome‐wide association studies. This manuscript builds upon a previous study, where differences in dose‐response curves between genotypes were constructed using the hill slope equation.

Conclusion

Overall, MANOVA was found to be the most powerful method for detecting real signals, and was also the most robust method for detection using alternatives generated with the previous simulation study. This method is also attractive because test statistics follow their expected distributions under the null hypothesis for both simulated and real data. The success of this method inspired the creation of the software program MAGWAS. MAGWAS is a computationally efficient, user‐friendly, open source software tool that works on most platforms and performs GWASs for individuals having multivariate responses using standard file formats.

Keywords:
Pharmacogenomics; Lymphoblastoid cell lines; Chemosensitivity; Chemotherapy; Temozolomide; Idarubicin; MANOVA; GWAS; Simulation study